Trial Profile
Study HZA106851: A Study of the Effects of Inhaled Fluticasone Furoate/GW642444 Versus Placebo on the HPA Axis of Adolescent and Adult Asthmatics.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2023
Price :
$35
*
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Prednisolone
- Indications Asthma
- Focus Adverse reactions; Registrational
- Sponsors GSK
- 21 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2010 Actual end date (September 2010) added as reported by ClinicalTrials.gov.
- 01 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.